1. Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma 
Yi-Bin Chen, Shuli Li, David C. Fisher, Jessica Driscoll, Candice Del Rio, Jeremy Abramson, Philippe Armand, Jeffrey Barnes, Jennifer Brown, Corey Cutler, Areej El-Jawahri, Vincent T. Ho, Ephraim Hochberg, Steven McAfee, Ronald Takvorian, Thomas R. Spitzer, Joseph H. Antin, Robert Soiffer, Eric Jacobsen 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 9, Pages (September 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Progression-free and overall survival in all patients (n = 42).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Progression-free and overall survival in patients undergoing tandem transplantation (n = 29).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions